To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

SEM image of the membrane protrusions of normal and intratumoral NK cells. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by ...

and on the other side binds to NK cells to stimulate a phenomenon known as antibody-dependent cellular cytotoxicity (ADCC), ...

Chimeric antigen receptors (CARs) are modular synthetic molecules that redirect immune cell cytotoxicity toward tumor cells expressing ... two types of CAR cell therapy: CAR-T and CAR-natural killer ...

Three-dimensional migration assays confirmed that SPON2 promoted the directional migration of NK cells toward tumor cells.

The following is a summary of “FcγR3A polymorphism influences natural killer cell activation and response to anti-PD-L1 ...

GloboCare announced that it has been granted the patent right and Certificate of Invention for its CAR-T and CAR-NK cell ...

2. Enhance NK cell proliferation and cytotoxicity Studies have shown a significant enhancement of NK cell proliferation and cytotoxicity with 4-1BBL, which triggers 4-1BB signaling to stimulate NK ...